Zdrowie i gospodarka · 09/02/2006

FDA Releases Draft Guidance on Pharmacogenetic and Genetic Tests for Heritable Markers

The Food and Drug Administration (FDA) has made available a draft guidance document that outlines the agency's expectations for preparing and reviewing premarket approval applications and 510(k) submissions for pharmacogenetic and genetic tests, including those that analyze multiple genetic markers simultaneously.